Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125186322 | 12518632 | 2 | F | 2015 | 20160808 | 20160630 | 20160810 | EXP | CN-GLAXOSMITHKLINE-CN2016GSK091366 | GLAXOSMITHKLINE | 34.00 | YR | F | Y | 63.00000 | KG | 20160810 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125186322 | 12518632 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 2 DF, BID | 20241 | 2 | DF | TABLET | BID | ||||||
| 125186322 | 12518632 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | 1 DF, BID | ZD0863 | 20241 | 1 | DF | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125186322 | 12518632 | 1 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125186322 | 12518632 | CA |
| 125186322 | 12518632 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125186322 | 12518632 | Abortion induced | |
| 125186322 | 12518632 | Exposure during pregnancy | |
| 125186322 | 12518632 | Trisomy 18 |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125186322 | 12518632 | 2 | 201506 | 0 |